New vessels after stroke: Postischemic neovascularization and regeneration

Cerebrovascular Diseases

Volumn 33, Issue 5, 2012, Pages 492-499

  Liman, T G ^a   Endres, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Acute ischemic stroke; Angiogenesis; Endothelial progenitor cells; Neovascularization; Regeneration

Indexed keywords

BIOLOGICAL MARKER;

ANGIOGENESIS; BRAIN ISCHEMIA; CELL LINEAGE; CELL PROLIFERATION; CEREBROVASCULAR DISEASE; DISEASE MARKER; DRUG TARGETING; ENDOTHELIAL PROGENITOR CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STROKE; VASCULAR DISEASE;

ANIMALS; BRAIN ISCHEMIA; ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; RECOVERY OF FUNCTION; REGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS; STROKE; VASCULAR DISEASES;

EID: 84859810531     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000337155     Document Type: Review

References (52)

1. Ramon y Cajal S: Degeneration and Regeneration of the Nervous System. New York, Oxford University Press, 1928.
2. Gurgo RD, Bedi KS, Nurcombe V: Current concepts in central nervous system regeneration. J Clin Neurosci 2002; 9: 613-617. (Pubitemid 35364729)
3. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O: Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 2002; 8: 963-970. (Pubitemid 35033700)
4. Thored P, Arvidsson A, Cacci E, Ahlenius H, Kallur T, Darsalia V, Ekdahl CT, Kokaia Z, Lindvall O: Persistent production of neurons from adult brain stem cells during recovery after stroke. Stem Cells 2006; 24: 739-747. (Pubitemid 44464779)
5. Wiltrout C, Lang B, Yan Y, Dempsey RJ, Vemuganti R: Repairing brain after stroke: A review on post-ischemic neurogenesis. Neurochem Int 2007; 50: 1028-1041. (Pubitemid 46962820)
6. Thored P, Wood J, Arvidsson A, Cammenga J, Kokaia Z, Lindvall O: Long-term neuroblast migration along blood vessels in an area with transient angiogenesis and increased vascularization after stroke. Stroke 2007; 38: 3032-3039. (Pubitemid 350035699)
7. Eguchi M, Masuda H, Asahara T: Endothelial progenitor cells for postnatal vasculogenesis. Clin Exp Nephrol 2007; 11: 18-25. (Pubitemid 46474961)
8. Risau W: Mechanisms of angiogenesis. Nature 1997; 386: 671-674. (Pubitemid 27193480)
9. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967. (Pubitemid 27087709)
10. Sabatier F, Camoin-Jau L, Anfosso F, Sampol J, Dignat-George F: Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence. J Cell Mol Med 2009; 13: 454-471.
11. Hirschi KK, Ingram DA, Yoder MC: Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008; 28: 1584-1595.
12. Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, Urbich C, Mildner-Rihm C, Martin H, Zeiher AM, Dimmeler S: Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 2003; 102: 1340-1346. (Pubitemid 36988041)
13. Hoenig MR, Bianchi C, Sellke FW: Hypoxia inducible factor-1 alpha, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: A unifying hypothesis. Curr Drug Targets 2008; 9: 422-435. (Pubitemid 352025218)
14. Iwakura A, Luedemann C, Shastry S, Hanley A, Kearney M, Aikawa R, Isner JM, Asahara T, Losordo DW: Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 2003; 108: 3115-3121. (Pubitemid 38031801)
15. Zheng H, Fu G, Dai T, Huang H: Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol 2007; 50: 274-280. (Pubitemid 47428975)
16. Tilling L, Chowienczyk P, Clapp B: Progenitors in motion: Mechanisms of mobilization of endothelial progenitor cells. Br J Clin Pharmacol 2009; 68: 484-492.
17. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, Crystal RG, Besmer P, Lyden D, Moore MA, Werb Z, Rafii S: Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002; 109: 625-637. (Pubitemid 34628725)
18. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-228. (Pubitemid 29377293)
19. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM: VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18: 3964-3972. (Pubitemid 29335849)
20. Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, Kamper U, Dimmeler S, Zeiher AM: Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: Proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111: 2981-2987. (Pubitemid 40814192)
21. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G: Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007. (Pubitemid 41262334)
22. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600. (Pubitemid 36204953)
23. Taguchi A, Matsuyama T, Moriwaki H, Hayashi T, Hayashida K, Nagatsuka K, Todo K, Mori K, Stern DM, Soma T, Naritomi H: Circulating cd34-positive cells provide an index of cerebrovascular function. Circulation 2004; 109: 2972-2975. (Pubitemid 38808318)
24. Taguchi A, Nakagomi N, Matsuyama T, Kikuchi-Taura A, Yoshikawa H, Kasahara Y, Hirose H, Moriwaki H, Nakagomi T, Soma T, Stern DM, Naritomi H: Circulating CD34-positive cells have prognostic value for neurologic function in patients with past cerebral infarction. J Cereb Blood Flow Metab 2009; 29: 34-38.
25. Sobrino T, Hurtado O, Moro MA, Rodriguez-Yanez M, Castellanos M, Brea D, Moldes O, Blanco M, Arenillas JF, Leira R, Davalos A, Lizasoain I, Castillo J: The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome. Stroke 2007; 38: 2759-2764. (Pubitemid 47494015)
26. Ghani U, Shuaib A, Salam A, Nasir A, Shuaib U, Jeerakathil T, Sher F, O'Rourke F, Nasser AM, Schwindt B, Todd K: Endothelial progenitor cells during cerebrovascular disease. Stroke 2005; 36: 151-153. (Pubitemid 40054193)
27. Yip HK, Chang LT, Chang WN, Lu CH, Liou CW, Lan MY, Liu JS, Youssef AA, Chang HW: Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke. Stroke 2007; 39: 69-74.
28. Bogoslovsky T, Chaudhry A, Latour L, Maric D, Luby M, Spatz M, Frank J, Warach S: Endothelial progenitor cells correlate with lesion volume and growth in acute stroke. Neurology 2010; 75: 2059-2062.
29. Bogoslovsky T, Spatz M, Chaudhry A, Maric D, Luby M, Frank J, Warach S: Stromal-derived factor-1[alpha] correlates with circulating endothelial progenitor cells and with acute lesion volume in stroke patients. Stroke 2011; 42: 618-625.
30. Pescini F, Cesari F, Giusti B, Sarti C, Zicari E, Bianchi S, Dotti MT, Federico A, Balestrino M, Enrico A, Gandolfo C, Gori AM, Abbate R, Pantoni L, Inzitari D: Bone marrowderived progenitor cells in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke 2010; 41: 218-223.
31. Jickling G, Salam A, Mohammad A, Hussain MS, Scozzafava J, Nasser AM, Jeerakathil T, Shuaib A, Camicioli R: Circulating endothelial progenitor cells and age-related white matter changes. Stroke 2009; 40: 3191-3196.
32. Rafat N, Beck GC, Pena-Tapia PG, Schmiedek P, Vajkoczy P: Increased levels of circulating endothelial progenitor cells in patients with moyamoya disease. Stroke 2009; 40: 432-438.
33. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, Zeiher AM, Dimmeler S: Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003; 9: 1370-1376. (Pubitemid 37466185)
34. Werner N, Priller J, Laufs U, Endres M, Böhm M, Dirnagl U, Nickenig G: Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: Effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 2002; 22: 1567-1572.
35. Laufs U, Werner N, Link A, Endres M, Wassmann S, Jurgens K, Miche E, Bohm M, Nickenig G: Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004; 109: 220-226. (Pubitemid 38114143)
36. Van Craenenbroeck EM, Conraads VM: Endothelial progenitor cells in vascular health: Focus on lifestyle. Microvasc Res 2010; 79: 184-192.
37. Fan Y, Shen F, Frenzel T, Zhu W, Ye J, Liu J, Chen Y, Su H, Young WL, Yang GY: Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Ann Neurol 2010; 67: 488-497.
38. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Suselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM: Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006; 355: 1210-1221. (Pubitemid 44427445)
39. Antonio N, Fernandes R, Rodriguez-Losada N, Jimenez-Navarro MF, Paiva A, de Teresa Galvan E, Goncalves L, Ribeiro CF, Providencia LA: Stimulation of endothelial progenitor cells: A new putative effect of several cardiovascular drugs. Eur J Clin Pharmacol 2010; 66: 219-230.
40. Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M, Petit E, Risau W: Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 2000; 156: 965-976. (Pubitemid 30626954)
41. Gertz K, Priller J, Kronenberg G, Fink KB, Winter B, Schrock H, Ji S, Milosevic M, Harms C, Bohm M, Dirnagl U, Laufs U, Endres M: Physical activity improves long-term stroke outcome via endothelial nitric oxide synthase-dependent augmentation of neovascularization and cerebral blood flow. Circ Res 2006; 99: 1132-1140. (Pubitemid 44729938)
42. Palmer TD, Willhoite AR, Gage FH: Vascular niche for adult hippocampal neurogenesis. J Comp Neurol 2000; 425: 479-494.
43. Kokovay E, Li L, Cunningham LA: Angiogenic recruitment of pericytes from bone marrow after stroke. J Cereb Blood Flow Metab 2006; 26: 545-555.
44. Potente M, Gerhardt H, Carmeliet P: Basic and therapeutic aspects of angiogenesis. Cell 2011; 146: 873-887.
45. Endres M, Engelhardt B, Koistinaho J, Lindvall O, Meairs S, Mohr JP, Planas A, Rothwell N, Schwaninger M, Schwab ME, Vivien D, Wieloch T, Dirnagl U: Improving outcome after stroke: Overcoming the translational roadblock. Cerebrovasc Dis 2008; 25: 268-278. (Pubitemid 351450431)
46. Shuaib A, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Diener HC, Ashwood T, Wasiewski WW, Emeribe U; SAINT II Trial Investigators: NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 2007; 357: 562-571. (Pubitemid 47236281)
47. Navaratna D, Guo S, Arai K, Lo EH: Mechanisms and targets for angiogenic therapy after stroke. Cell Adh Migr 2009; 3: 216-223.
48. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, Greenberg DA: VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 2003; 111: 1843-1851. (Pubitemid 38057729)
49. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, Bruggen N, Chopp M: VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 2000; 106: 829-838.
50. Hiesinger W, Perez-Aguilar JM, Atluri P, Marotta NA, Frederick JR, Fitzpatrick JR 3rd, McCormick RC, Muenzer JR, Yang EC, Levit RD, Yuan LJ, Macarthur JW, Saven JG, Woo YJ: Computational protein design to reengineer stromal cell-derived factor-1alpha generates an effective and translatable angiogenic polypeptide analog. Circulation 2011; 124:S18-S26.
51. Onteniente B, Polentes J: Regenerative medicine for stroke - Are we there yet? Cerebrovasc Dis 2011; 31: 544-551.
52. Savitz SI, Chopp M, Deans R, Carmichael ST, Phinney D, Wechsler L: Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II. Stroke 2011; 42: 825-829.